Obermatt
See Similar Stocks →

Stryker

NYQ:SYK · US8636671013
Health Care Equipment & SuppliesLarge

360

60
EV / EBIT31
Price / Owner Earnings31
Owner Earnings Yield43
Dividend Yield99
Price/Sales34
EV / Gross Profit27
Price/Book39
Return on Capital73
Cash Return on Capital73
Return on Equity69
EBIT Margin84
Gross Profitability48
Cash Conversion49
Accruals71
Owner Earnings Margin69
Sales growth49
Profit Growth100
Long-Term EPS Growth50
Owner Earnings Growth69
Reinvestment53
Price momentum44
Debt load47
Refinancing50
Debt Payback42
Liquidity88
Analyst ratings42
Opinion Changes36
Price Target Upside68
Market mood81
Value Creation16/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Stryker generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePublic Company
ExchangeNYSE
Founded1946
Employees40,424
Websitestryker.com
ISINUS8636671013
Last UpdateApr 2, 2026
Indices
Robotics & 3D PrintingS&P 500 (USA)D.J. US Health CareD.J. US Medical Equipment
Themes
NeurologyUrologyBiomedical EngineeringPain ManagementArtificial IntelligenceOrthopaedicsSurgeryNeuroscienceBiotechnologyHealth CareLife ScienceMedicalMedical Device

Description

Stryker Corporation (Stryker) is a global leader in medical technologies. The company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside the company’s customers arou…

Analysis

Beloved champion

Stryker Corporation is a beloved champion: its quality is genuine, and the market already prices it as exceptional.

The price is expensive. You pay 31.1× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 12% yearly growth; analysts expect 10%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is adequate. The company scores 16/20 on our value-creation score: strong value creator.

What to watch: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
100
2023202420252026

All-time high

100

Jun 2026

All-time low

63

Feb 2025

Average rank

83

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
34
17
23
48
Price/Earnings
28
35
37
56
Price/Book
39
20
25
45
Dividend Yield
99
88
91
94
Value (overall)
70
49
52
49

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Stryker with its peers
Penumbra
NYQ:PEN
60
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
CONMED
NYQ:CNMD
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Globus Medical
NYQ:GMED
98
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Enovis
NYQ:ENOV
40
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Omnicell
NSQ:OMCL
80
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
SI-BONE
NMQ:SIBN
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →